VERAXA Biotech (NASDAQ: VRXA), an emerging leader in designing novel cancer therapies, presented its first in vivo ...

A Tokyo biotech company that grows therapeutic cells inside threads of seaweed-based gel has chosen University City as its ...

Krystal Biotech's (KRYS) pilot study of KB113 as a treatment for basal cell carcinomas or BCC in patients with Gorlin syndrome demonstrated a substantial regression in lesions, th ...

LB2501 is an off-the-shelf in vivo CAR-T therapy designed to generate dual-targeting CD19/CD20 CAR-T cells directly within ...

Biotechs must now adopt new commercial models if breakthrough treatments are to reach the patients they’re designed to help.

Colossal Biosciences uses AI to identify genetic targets for dodo revival, while studying the Nicobar pigeon and conservation ...

The list of departing ASX biotech CEOs continues to swell, with Medical Developments chief Brent MacGregor signing off today.

A US biotech company says it is making progress toward its goal of resurrecting the dodo, the famous flightless bird with a ...

Its valuation is driven by a proprietary agentic AI platform and potential first-in-class cancer treatment Read more at The ...

UK-based deep-tech ingredient solutions company MicroLub has secured US$10M to scale up its fat-replacement biotechnology, ...

Rebranding the biotech company memorializes the brother of AI Financial's Chairman, Zach Witkoff, and aligns with the ...